NCT06747897

An Observational Study to Gather Real-World User Feedback on DIPROBASE® Advanced Eczema Cream in Adults and Children With Eczema or Dry Skin

Retrospective Consumer Experience on Former Use of DIPROBASE Advanced Eczema Cream® UI 1613882

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 300 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an observational study which means only data are collected from participants about their experience and symptoms, who received their usual treatment without any intervention from the study sponsor. Atopic dermatitis, also known as eczema, is a long-lasting skin disease that causes redness, swelling, dryness, cracking, and intense itching. Xerosis is the scientific wording to describe dry skin. This condition is caused by a weakened skin barrier that does not hold moisture well. DIPROBASE® advanced eczema cream is already available for use in the UK. It moisturizes and protects the skin. This study is being done to understand how people use DIPROBASE® Advanced Eczema Cream and how consistently they adhere to its recommended use in their daily routines. In this study, participants will be asked to fill in an online questionnaire about their eczema symptoms and experience with DIPROBASE® Advanced Eczema Cream. No treatment advice will be given as a part of this study. The main purpose of this study is to gather feedback from people in the UK who have used DIPROBASE® Advanced Eczema Cream to treat their eczema or their dry skin condition. To do this, researchers will collect the following information from participants: * intensity of eczema symptoms * whether the cream provides a cooling or soothing effect * whether the cream helps to ease the symptoms like itchiness, pain, or dryness It is planned to identify and collect user data from November 2024 to January 2025. Participants will be recruited through a consumer database available with an external partner or via social media. In this study, only data are collected. No visits or tests are required as part of this study.

Conditions

• Dermatitis, Atopic

Interventions

Type	Name	Description
DEVICE	MINERAL OIL + PETROLATUM (DIPROBASE® Advanced Eczema Cream, BAY987534, UI 1613882)	Product experience is assessed based on the answers provided by participants on the questions provided to them using an online questionnaire.

Timeline

• Start date: 2024-11-28
• Primary completion: 2024-12-12
• Completion: 2024-12-12
• First posted: 2024-12-24
• Last updated: 2025-01-17

Locations

1 site across 1 country: United Kingdom